[HTML][HTML] mRNA vaccines against SARS-CoV-2: Advantages and caveats
M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
[PDF][PDF] Chocarro de Erauso
M Echaide - Bocanegra, A., Blanco, E., Kochan, G. and …, 2023 - academica-e.unavarra.es
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
[HTML][HTML] Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History
P Nazaruk, I Tkaczyk, M Monticolo, AM Jędrzejczak… - Vaccines, 2023 - mdpi.com
Immunization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
significantly limited the spread of coronavirus disease 2019 (COVID-19) and reduced the …
significantly limited the spread of coronavirus disease 2019 (COVID-19) and reduced the …
Comparative analysis between STANDARD‐E Covi‐FERON ELISA with pre‐existing IFN‐γ release assays and determination of the optimum cutoff value for …
J Jang, K Widyasari, S Kim - Journal of Clinical Laboratory …, 2023 - Wiley Online Library
Background Interferon‐gamma (IFN‐γ) release assays (IGRAs) are useful for the
assessment of the T‐cell response to severe acute respiratory syndrome‐coronavirus‐2 …
assessment of the T‐cell response to severe acute respiratory syndrome‐coronavirus‐2 …
[HTML][HTML] Prevalence of COVID-19 in Kidney Transplant Patients in Relation to Their Immune Status after Repeated Anti-SARS-CoV-2 Vaccination
S Sakalauskaite, R Vaiciuniene, N Kusleikaite-Pere… - Pathogens, 2023 - mdpi.com
The prospective study was conducted to evaluate the prevalence of COVID-19 in kidney
transplant patients in relation to their immune status after three doses of the BNT162b2 …
transplant patients in relation to their immune status after three doses of the BNT162b2 …
[引用][C] Mrna vaccines against sars-cov-2: advantages and caveats
M Echaide Górriz, L Chocarro… - International Journal of …, 2023 - MDPI